|
TSEN15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.792000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.041800E-04 |
| Normal-vs-Stage2 |
1.047600E-01 |
| Normal-vs-Stage3 |
3.159700E-02 |
| Normal-vs-Stage4 |
3.259400E-01 |
| Stage1-vs-Stage2 |
3.345400E-01 |
| Stage1-vs-Stage3 |
4.891800E-01 |
| Stage1-vs-Stage4 |
2.824400E-02 |
| Stage2-vs-Stage3 |
7.765400E-01 |
| Stage2-vs-Stage4 |
4.730200E-01 |
| Stage3-vs-Stage4 |
2.760000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.762000E-04 |
| Normal-vs-AfricanAmerican |
1.836960E-03 |
| Normal-vs-Asian |
4.768600E-01 |
| Caucasian-vs-AfricanAmerican |
4.488000E-01 |
| Caucasian-vs-Asian |
7.197200E-01 |
| AfricanAmerican-vs-Asian |
4.452000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.401200E-03 |
| Normal-vs-Female |
8.627600E-04 |
| Male-vs-Female |
6.190200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.325800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.192300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.743800E-03 |
| Normal-vs-Age(81-100Yrs) |
2.218400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.414400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.773800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.798000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.518200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.813800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.019200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.447700E-02 |
| Normal-vs-Grade 2 |
1.621330E-03 |
| Normal-vs-Grade 3 |
7.169100E-04 |
| Normal-vs-Grade 4 |
4.231600E-01 |
| Grade 1-vs-Grade 2 |
6.990200E-01 |
| Grade 1-vs-Grade 3 |
6.906800E-01 |
| Grade 1-vs-Grade 4 |
2.417600E-01 |
| Grade 2-vs-Grade 3 |
8.986200E-01 |
| Grade 2-vs-Grade 4 |
1.076570E-01 |
| Grade 3-vs-Grade 4 |
6.271800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.54700000000774E-05 |
| Normal-vs-ccB subtype |
1.804020E-01 |
| ccA subtype-vs-ccB subtype |
2.336000E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.545000E-03 |
| Normal-vs-N1 |
9.239000E-01 |
| N0-vs-N1 |
3.766800E-01 |
|
|
